reports
GENFIT announces intention to voluntarily delist American Depositary S...
GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market GENFIT’s decision to delist from Nasdaq reflects strategic intent to simplify corporate structure and improve operational efficiencyGENFIT remains listed on the regulated market of Euronext Paris as its primary trading market Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); October 30, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, ...
GENFIT annonce son intention de procéder au retrait volontaire de la c...
GENFIT annonce son intention de procéder au retrait volontaire de la cotation de ses « American Depositary Shares » sur le Nasdaq Global Select Market La décision de GENFIT de retrait du Nasdaq traduit une volonté stratégique de simplifier sa structure organisationnelle et d'améliorer son efficacité opérationnelleLes actions de GENFIT restent cotées sur le marché réglementé Euronext Paris, son marché principal Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 30 octobre 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration...
SUBC - EX. DIVIDEND NOK 6.50 TODAY
SUBC - EX. DIVIDEND NOK 6.50 TODAY Issuer: Subsea 7 S.A.Ex. date: 29 October 2025Dividend amount: NOK 6.50Announced currency: Norwegian Krone Contact for investment community enquiries:Katherine TonksDirector, Investor RelationsTel 8ir@@subsea7.com This information is published in accordance with the requirements of the Continuing Obligations.
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver ...
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025 Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosisNew Iqirvo® PBC and PSC data to be presented by partner Ipsen, underscoring its potential in rare cholestatic liver diseases Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), October 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of...
GENFIT annonce des avancées dans ses programmes ACLF lors du congrès A...
GENFIT annonce des avancées dans ses programmes ACLF lors du congrès AASLD The Liver Meeting® 2025 Plusieurs posters et présentations avec de nouvelles données relatives à trois de nos programmes dans l’ACLF, dont des données de G1090N dans des modèles précliniques, de nouvelles données en vie réelle, et des données de biomarqueurs dans la cirrhose Nouvelles données sur Iqirvo® dans la PBC et la PSC présentées par notre partenaire Ipsen, soulignant son potentiel dans le traitement des maladies hépatiques cholestatiques rares Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (S...
PRESS RELEASE: NACON: 4.5% INCREASE IN SALES FOR THE SECOND QUARTER 20...
PRESS RELEASE: NACON: 4.5% INCREASE IN SALES FOR THE SECOND QUARTER 2025-26 AT €46.8 M - ENGLISH VERSION Press release Lesquin, October 27, 2025 - 18:00 4.5% INCREASE IN SALESFOR THE SECOND QUARTER 2025-26 AT €46.8 M CONFIRMATION OF THE GROUP'S ANNUAL TARGETS NACON (ISIN FR0013482791) today publishes its consolidated sales for the first half of its 2025/26 financial year (period from 1 April to 30 September 2025). IFRS – M€2025-262024-25ChangeSalesFirst Quarter (April-June)31.332.3-2.9% Second Quarter (Jul. -Sept. )46.844,8+4.5% Games3...
- Ana Arjona-Martinez
- Chaima Ferrandon
- Emmanuel Matot
- Sven Edelfelt
CEC CECONOMY AG
DG VINCI SA
FGR EIFFAGE SA
KORI KORIAN SA
TPE PVA TEPLA AG
BIG BIGBEN INTERACTIVE SA
SAVE SAVENCIA SA
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
VASTB VASTNED RETAIL BELGIUM NV
KTCG KAPSCH TRAFFICCOM
WAF SILTRONIC AG
RENE REDES ENERGETICAS NACIONAIS SA
SMHN SUESS MICROTEC AG
LFDE LA FRANCAISE DE L'ENERGIE SA
NACON NACON SASU
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
SPG SPRINGER NATURE AG & CO. KGAA
- Ana Arjona-Martinez
- Chaima Ferrandon
- Emmanuel Matot
- Sven Edelfelt
CEC CECONOMY AG
DG VINCI SA
FGR EIFFAGE SA
KORI KORIAN SA
TPE PVA TEPLA AG
BIG BIGBEN INTERACTIVE SA
SAVE SAVENCIA SA
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
VASTB VASTNED RETAIL BELGIUM NV
KTCG KAPSCH TRAFFICCOM
WAF SILTRONIC AG
RENE REDES ENERGETICAS NACIONAIS SA
SMHN SUESS MICROTEC AG
LFDE LA FRANCAISE DE L'ENERGIE SA
NACON NACON SASU
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
SPG SPRINGER NATURE AG & CO. KGAA
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Martin Mauseth
- Njål Kleiven
- Stian Wibstad
- Maud Servagnat
- Maxime Dubreil
COMMUNIQUE DE PRESSE: NACON: HAUSSE DE 4,5% DU CHIFFRE D’AFFAIRES DU 2...
COMMUNIQUE DE PRESSE: NACON: HAUSSE DE 4,5% DU CHIFFRE D’AFFAIRES DU 2ème TRIMESTRE 2025-26 À 46,8 M€ Communiqué de presse Lesquin, 27 octobre 2025 - 18h00 HAUSSE DE 4,5% DU CHIFFRE D’AFFAIRES DU 2ème TRIMESTRE 2025-26 À 46,8 M€ CONFIRMATION DES OBJECTIFS ANNUELS DU GROUPE NACON (ISIN FR0013482791) publie ce jour son chiffre d’affaires consolidé du 2ème trimestre de l’exercice 2025-26 (période du 1er juillet 2025 au 30 septembre 2025). IFRS – M€2025-262024-25VariationChiffre d’affaires1er Trimestre (avril-juin)31,332,3-2,9% 2ème Tr...
- Anthony Dick
- Emira Sagaama
- Michael Foundoukidis
VAC PIERRE & VACANCES SA
NXI NEXITY SA CLASS A
MF WENDEL SE
EXE EXEL INDUSTRIES SA
BIO BB BIOTECH AG
BLC BASTIDE LE CONFORT MEDICAL SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
MRN MERSEN SA
FII LISI SA
GBT GUERBET SA
ATE ALTEN SA
FR VALEO SE
XIOR XIOR STUDENT HOUSING N.V.
MIL BANK MILLENNIUM SA
SAVE SAVENCIA SA
MBWS MARIE BRIZARD WINE & SPIRITS SA
TIETO TIETOEVRY OYJ
VIS VISCOFAN S.A.
CCC CCC SA
AALB AALBERTS N.V.
CARM CARMILA SAS
LIGHT SIGNIFY NV
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
BRAV BRAVIDA HOLDING AB
LFDE LA FRANCAISE DE L'ENERGIE SA
HOME NEINOR HOMES SA
MDM MAISONS DU MONDE SA
SMCP SMCP SA
RBO ROCHE BOBOIS INTERNATIONAL SAS
TMV TEAMVIEWER AG
ZGN ERMENEGILDO ZEGNA NV
SPM SAIPEM S.P.A.
AROBS AROBS TRANSILVANIA SOFTWARE SA
R3NK RENK GROUP AG
PLNW PLANISWARE
4X0 STEYR MOTORS AG
LOCAL SOLOCAL GROUP
- Anthony Dick
- Emira Sagaama
- Michael Foundoukidis
VAC PIERRE & VACANCES SA
NXI NEXITY SA CLASS A
MF WENDEL SE
EXE EXEL INDUSTRIES SA
BIO BB BIOTECH AG
BLC BASTIDE LE CONFORT MEDICAL SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
MRN MERSEN SA
FII LISI SA
GBT GUERBET SA
ATE ALTEN SA
FR VALEO SE
XIOR XIOR STUDENT HOUSING N.V.
MIL BANK MILLENNIUM SA
SAVE SAVENCIA SA
MBWS MARIE BRIZARD WINE & SPIRITS SA
TIETO TIETOEVRY OYJ
VIS VISCOFAN S.A.
CCC CCC SA
AALB AALBERTS N.V.
CARM CARMILA SAS
LIGHT SIGNIFY NV
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
LFDE LA FRANCAISE DE L'ENERGIE SA
HOME NEINOR HOMES SA
MDM MAISONS DU MONDE SA
SMCP SMCP SA
RBO ROCHE BOBOIS INTERNATIONAL SAS
TMV TEAMVIEWER AG
ZGN ERMENEGILDO ZEGNA NV
SPM SAIPEM S.P.A.
AROBS AROBS TRANSILVANIA SOFTWARE SA
R3NK RENK GROUP AG
PLNW PLANISWARE
4X0 STEYR MOTORS AG
LOCAL SOLOCAL GROUP
- Fatma Agnès Hamdani
- Fatma Agnès Hamdani
Marie Brizard Wine & Spirits: Q3 2025 revenues
Marie Brizard Wine & Spirits: Q3 2025 revenues Charenton-le-Pont, 23 October 2025 Q3 2025 revenues Sales down 10.5%1 vs. Q3 2024 Significant decline in the France cluster due to difficult annual commercial negotiations with Off-Trade chainsSlight decline in international sales amid a global market slowdown Nine-month 2025 revenues down 9.2%1 at €127.5m France: continued sharp decline in sales, down 19.3% for the first nine months against a backdrop of challenging annual commercial negotiations with the Off-Trade and continuing dec...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.